<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------
SCHEDULE 13G
INFORMATION STATEMENT PURSUANT TO RULES 13D-1 AND 13D-2
(AMENDMENT NO. 9)
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Name of Issuer)
Common Stock, par value $0.01 per share
---------------------------------------
(Title of Class of Securities)
50540R 10 2
--------------
(CUSIP Number)
(CONTINUED ON FOLLOWING PAGE(S))
Page 1 of 7
<PAGE>
13G
CUSIP NO. 50540R 10 2 Page 2 of 7
- -------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
NATIONAL HEALTH CARE GROUP, INC.
- -------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF MEMBER OF A GROUP (a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------
3. SEC USE ONLY
- -------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OR ORGANIZATION
DELAWARE
- -------------------------------------------------------------------------------
5. SOLE VOTING POWER
-0-
-----------------------------------------------------------
NUMBER 6. SHARED VOTING POWER
OF SHARES
BENEFICIALLY 7,105,644
OWNED BY -----------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH -0-
-----------------------------------------------------------
8. SHARED DISPOSITIVE POWER
7,105,644
- -------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,105,644
- -------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES [ ]
- -------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.7%
- -------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
CO
<PAGE>
13G
CUSIP NO. 50540R 10 2 Page 3 of 7
- -------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
MAFCO HOLDINGS INC.
- -------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF MEMBER OF A GROUP (a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------
3. SEC USE ONLY
- -------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OR ORGANIZATION
DELAWARE
- -------------------------------------------------------------------------------
5. SOLE VOTING POWER
-0-
-----------------------------------------------------------
NUMBER 6. SHARED VOTING POWER
OF SHARES
BENEFICIALLY 7,105,644
OWNED BY -----------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH -0-
-----------------------------------------------------------
8. SHARED DISPOSITIVE POWER
7,105,644
- -------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,105,644
- -------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES [ ]
- -------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.7%
- -------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
CO
<PAGE>
13G
CUSIP NO. 50540R 10 2 Page 4 of 7
Item 1(a): Name of Issuer.
---------------
LABORATORY CORPORATION OF AMERICA HOLDINGS (the
"Company")
Item 1(b): Address of Issuer's Principal Executive Offices.
------------------------------------------------
358 South Main Street
Burlington, North Carolina 27215
Item 2(a): Name of Persons Filing.
-----------------------
National Health Care Group, Inc. ("National Health")
is an indirect wholly-owned subsidiary of Mafco
Holdings Inc. ("Mafco"). All of the capital stock of
Mafco is owned by Ronald O. Perelman.
Item 2(b): Address of Principal Business Office.
-------------------------------------
The principal business offices of National Health
are located at 35 East 62nd Street, New York, New
York 10021. The principal business offices of Mafco
are located at 35 East 62nd Street, New York, New
York 10021.
Item 2(c): Citizenship.
------------
National Health and Mafco each are Delaware
corporations.
Item 2(d): Title of Class of Securities.
-----------------------------
Common Stock, par value $.01 per share (the
"Shares").
Item 2(e): CUSIP Number.
-------------
50540R 10 2
Item 3: Not Applicable
Item 4: Ownership.
----------
National Health owns 7,105,644 Shares, which
represented approximately 5.7% of the total number
of Shares outstanding on December 31, 1998. Mafco
may be deemed to beneficially own the Shares owned
by National
<PAGE>
13G
CUSIP NO. 50540R 10 2 Page 5 of 7
Health. Ronald O. Perelman owns all of the capital
stock of Mafco.
(a) Amount Beneficially Owned:
7,105,644 Shares
(b) Percent of Class:
Approximately 5.7% based upon 125,272,546
Shares outstanding on December 31, 1998.
(c) Number of shares as to which such person has:
(i) Sole power to vote or to
direct the vote..................-0-
(ii) Shared power to vote or
to direct the vote.........7,105,644
(iii) Sole power to dispose
or to direct the
disposition of...................-0-
(iv) Shared power to dispose
or to direct the
disposition of.............7,105,644
In addition, National Health owns warrants to
purchase 3,290,421 Shares at $22.00 (subject to
adjustment). Such warrants are exercisable on
April 28, 2000.
Item 5: Owner of Five Percent or Less of a Class.
-----------------------------------------
Not Applicable
Item 6: Ownership of More than Five Percent on Behalf of
Another Person.
------------------------------------------------
Not Applicable
Item 7: Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on By the
Parent Holding Company.
----------------------------------------------------
Not Applicable
<PAGE>
13G
CUSIP NO. 50540R 10 2 Page 6 of 7
Item 8: Identification and Classification of Members of the
Group.
---------------------------------------------------
Not Applicable
Item 9: Notice of Dissolution of Group.
-------------------------------
Not Applicable
Item 10: Certification.
--------------
Not Applicable
<PAGE>
13G
CUSIP NO. 50540R 10 2 Page 7 of 7
Signature
---------
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: January 13, 1999
NATIONAL HEALTH CARE GROUP, INC.
By: /s/ Glenn P. Dickes
--------------------------------
Name: Glenn P. Dickes
Title: Vice President
MAFCO HOLDINGS INC.
By: /s/ Glenn P. Dickes
--------------------------------
Name: Glenn P. Dickes
Title: Senior Vice President
